Condition
Demodex Blepharitis
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (1)
P 4 (2)
Trial Status
Completed2
Recruiting1
Not Yet Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07561450Phase 4Not Yet RecruitingPrimary
Demodex Blepharitis in Scleral Lens Wearers
NCT07400965Phase 2RecruitingPrimary
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
NCT07169461Not ApplicableEnrolling By InvitationPrimary
Effectiveness of Low Level Light Therapy and Intense Pulse Light on Mite Count as Adjuntive Therapies in Demodex Blepharitis Using Artificial Intelligent Program (Ai-Demodex)
NCT06182358Phase 4CompletedPrimary
Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
NCT04780165Not ApplicableCompletedPrimary
Efficacy and Tolerability of Blephademodex Wipes
Showing all 5 trials